KENNETH HASKELL BROOKLER, MD
Medical Practice at 77 St, New York, NY
License number
New York 103359
Category
Medical Practice
Type
Otology & Neurotology
Address
Address
111 E 77Th St, New York, NY 10021
Phone
(212) 861-6900
(212) 472-0134 (Fax)
(212) 472-0134 (Fax)
Personal information
See more information about KENNETH HASKELL BROOKLER at radaris.comName
Address
Phone
111 77Th St, New York, NY 10001
111 77Th St, New York, NY 10021
7 Franklin Ave, Rye, NY 10580
Professional information
Dr. Kenneth H Brookler, New York NY - MD (Doctor of Medicine)
Specialties:
Ear, Nose, and Throat
Address:
NEUROTOLOGIC ASSOCIATES
111 E 77Th St, New York 10075
(212) 879-0408 (Phone), (212) 472-0134 (Fax)
111 E 77Th St, New York 10075
(212) 879-0408 (Phone), (212) 472-0134 (Fax)
Certifications:
Otolaryngology, 1968
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Manitoba / Faculty of Medicine
Winnipeg Genl Hosp
Deer Lodge Hosp
Mayo Grad Sch Med Ctr
University of Manitoba / Faculty of Medicine
Winnipeg Genl Hosp
Deer Lodge Hosp
Mayo Grad Sch Med Ctr
Kenneth Haskell Brookler, New York NY
Specialties:
Ear, Nose & Throat Doctor
Address:
111 E 77Th St, New York, NY 10075
Education:
University of Manitoba, Faculty of Medicine - Doctor of Medicine
Health Sciences Centre Winnipeg - Residency - Surgery
Health Sciences Centre Winnipeg - Residency - Surgery
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology
Use Of Bisphosphonates For Otosclerosis
US Patent:
2005004, Mar 3, 2005
Filed:
Aug 25, 2004
Appl. No.:
10/926565
Inventors:
Kenneth Brookler - New York NY, US
International Classification:
A61K031/675, A61K031/66, A61K031/59
US Classification:
514089000, 514102000, 514167000
Abstract:
A method of treating otosclerosis in a human in need thereof by administering a bisphosphonate in a defined dosing schedule. The invention demonstrates an effective response and sustained benefit in the treatment of otosclerosis. Particularly, the method involves administration of a bisphosphonate in a stepped-up dosage amount, e.g., in a dose that is at least one and a half times the recommended dose for osteoporosis. It also includes administration of a time-dependent dose of more than one bisphosphonate, specifically, alternating administration of a first bisphosphonate with a second bisphosphonate. The inventive method further includes intravenous administration of a bisphosphonate, and optionally oral administration of a bisphosponate. The present invention further contemplates a kit for facilitating the alternating bisphosphonate dosing schedule